Baseline SAS Score | Follow-up SAS score | p-value | Baseline NRS ≥ 4 | |||||
---|---|---|---|---|---|---|---|---|
n (%) | Median (IQR) | n (%) | Median (IQR) | n (%) | n (%) with NRS ≥ 1-point improvement | n (%) with NRS ≥ 4 at first follow-up | ||
Sleep disturbance | 177 (71.1) | 3 (1,6) | 76 (30.5) | 2 (0,5) | < 0.001 | 84 (49.1) | 21 (24.1) | 18 (39.1) |
Anorexia | 187 (75.1) | 3 (1,7) | 74 (29.7) | 2 (0,5) | 0.720 | 93 (49.8) | 22 (21.5) | 16 (32.7) |
Nausea | 180 (72.3) | 1 (0,5) | 75 (30.1) | 1 (0,3) | 0.137 | 51 (28.3) | 14 (27.5) | 7 (30.4) |
Bowel | 183 (73.5) | 3 (1,7) | 75 (30.1) | 3 (1,5) | 0.062 | 89 (48.6) | 34 (21.9) | 25 (53.1) |
Dyspnoea | 176 (70.7) | 2 (0,5) | 75 (30.1) | 2 (0,4) | 0.580 | 63 (35.8) | 14 (22.2) | 11 (44.0) |
Fatigue | 188 (75.5) | 7 (5,8) | 75 (30.1) | 3 (1,5) | 0.059 | 155 (82.6) | 34 (21.9) | 53 (66.3) |
Paina | 186 (74.7) | 6 (3,8) | 76 (30.5) | 2 (0,4) | 0.002 | 128 (68.8) | 28 (21.9) | 42 (52.5) |
Mood | 176 (70.1) | 4 (1,6) | 71 (28.5) | 6 (4,7) | 0.002 | 96 (54.5) | 26 (27.1) | 26 (48.1) |
Other | 25 (10.1) | 7 (6,9) | 12 (4.8) | 5 (1,7) | 0.021 | 22 (88) | 4 (18.2) | 2 (18.2) |
Wellbeing/QOL | 177 (71.1) | 5 (4,7) | 72 (28.9) | 2 (0,5) | < 0.001 | 134 (75.7) | 356 (26.1) | 49 (63.6) |
Symptom composite score, mean (SD) | 183 (73.5) | 30.9 (15.5) | 75 (30.1) | 25.9 (13.4) | 0.028 |